glutathione and cancer Utilizing glutathione-triggered nanoparticles to enhance chemotherapy of lung by reprograming the tumor microenvironment Glutathione-mediated nanomedicines for cancer diagnosis
Description
The peptide distributes across 5 liters of blood volume
What the Research Shows Primary mechanisms include VEGFR2 activation and Akt-eNOS signaling (DOI: 10.1007/s00109-016-1488-y), nitric oxide modulation (PMC7555539), fibroblast migration enhancement (DOI: 10.1152/japplphysiol.00945.2010), and growth hormone receptor upregulation (PMC6271067)
Proper peptide storage maintains potency
In one older study, subcutaneous injections of TA-1 (1.6mg) twice a week for up to 52 weeks led to clearance of serum hepatitis B virus and antigen in up to 40.6% of patients
The peptide degradation problem is very much a real phenomenon, and is the furthest thing away from theoretical
